TransMedics Group (NASDAQ:TMDX) Stock Price Expected to Rise, Oppenheimer Analyst Says
TransMedics Group (NASDAQ:TMDX – Free Report) had its price objective upped by Oppenheimer from $130.00 to $150.00 in a research note published on Tuesday,Benzinga reports. They currently have an outperform rating on the stock. A number of other equities research analysts also recently issued reports on TMDX. Canaccord Genuity Group reissued a “buy” rating and […]
TransMedics Group (NASDAQ:TMDX – Free Report) had its price objective upped by Oppenheimer from $130.00 to $150.00 in a research note published on Tuesday,Benzinga reports. They currently have an outperform rating on the stock. A number of other equities research analysts also recently issued reports on TMDX. Canaccord Genuity Group reissued a “buy” rating and […]
